Gene: C7orf25
Official Full Name: chromosome 7 open reading frame 25provided by HGNC
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19233 | C7orf25 Knockout cell line (HeLa) | Human | C7orf25 | 1:3~1:6 | Negative | Online Inquiry |
KO19234 | C7orf25 Knockout cell line (HCT 116) | Human | C7orf25 | 1:2~1:4 | Negative | Online Inquiry |
KO19235 | C7orf25 Knockout cell line (HEK293) | Human | C7orf25 | 1:3~1:6 | Negative | Online Inquiry |
KO19236 | C7orf25 Knockout cell line (A549) | Human | C7orf25 | 1:3~1:4 | Negative | Online Inquiry |
C7orf25 Gene Knockout Cell Lines represent a cutting-edge tool in molecular biology that involves the targeted disruption of the C7orf25 gene, facilitating in-depth research into gene function, regulation, and associated cellular pathways. These cell lines are engineered using advanced CRISPR/Cas9 technology, which allows for precise modifications at the genomic level. By creating knockout models, researchers can elucidate the role of the C7orf25 gene in various biological processes, including cell proliferation, differentiation, and disease mechanisms.
The primary function of these knockout cell lines lies in their ability to provide a controlled environment for studying the phenotypic consequences of gene loss. By comparing the knockout cell lines with their wild-type counterparts, scientists can better understand the functional implications of C7orf25 in health and disease, including its potential role in cancer or metabolic disorders. This is crucial for identifying novel therapeutic targets and advancing personalized medicine strategies.
C7orf25 Gene Knockout Cell Lines hold significant scientific importance within both research and clinical settings. They serve as robust models for drug screening, functional genomics studies, and therapeutic strategies evaluating the impact of gene editing. The unique ability to observe the knockout effects on cellular behavior and gene expression patterns bridges the gap between laboratory discovery and potential clinical applications.
What sets these knockout cell lines apart from other genetic models is their specificity and the efficiency of gene disruption. While traditional methods, such as RNA interference, can yield off-target effects and incomplete knockdown, the CRISPR technology used in generating these cell lines results in a definitive and reproducible knockout. Additionally, the ease of integration into existing workflows enhances their usability across diverse research disciplines.
For researchers and clinicians focused on gene function, these cell lines represent invaluable assets that accelerate the pace of discovery. They empower studies that have significant implications for understanding complex diseases and contributing to groundbreaking therapeutic advancements.
Our company specializes in providing high-quality genomic products, including state-of-the-art knockout models, underpinned by a commitment to scientific excellence and innovation. With a focus on supporting the research community, we enable scientists to explore the uncharted territories of genetics and cell biology with confidence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.